Bayesian Hierarchical Modeling for Categorical Longitudinal Data from Sedation Measurements
Table 5
Estimated posterior means and %95 intervals.
Variables
Model 1
Model 2
Model 3
Model 4
Model 5
Group
C
−3,017 (−4,121; 7,016)
−2,981 (−3,115; 6,812)
−2,17 (−2,29; 5,61)
−4,21 (−5,51; 9,82)
−3,81 (−6,61; 3,43)
D
−52,911 (−53,131; −50,97)
−48,17 (−52,16; −46,13)
−37,4 (−48,1; −29,8)
−41,4 (−53,1; −26,1)
−43,5 (−51,4; −31,5)
L
16,931 (−21,431; 23,71)
15,81 (−21,03; 21,74)
10,71 (−5,03; 15,2)
13,15 (−4,81; 27,16)
17,51 (−3,85; 21,12)
Age
0,021 (−0,025; 0,039)
0,018 (−0,074; 0,041)
0,17 (−0,43; 0,48)
0,07 (−0,29; 0,61)
0,11 (−0,41; 0,23)
Sex
−0,331 (−0,773; 0,121)
−0,365 (−0,443; 0,141)
−0,91 (−1,21; 0,78)
−0,45 (−1,54; 1,131)
−0,71 (−1,13; 1,45)
Disease
−0,231 (−0,328; 0,174)
−0,261 (−0,317; 0,161)
−0,98 (−1,67; 0,71)
−0,631 (−1,27; 0,617)
−0,73 (−1,11; 0,62)
Weight
−0,1417 (−0,151; 0,1317)
−0,1321 (−0,1617; −0,117)
−0,67 (−0,87; −0,25)
−0,24 (−0,43; 0,12)
−0,34 (−0,84; −0,17)
Comp
0,081 (0,065; 0,093)
0,076 (0,051; 0,113)
0,162 (0,101; 0,312)
0,151 (0,09; 0,27)
0,101 (0,06; 0,17)
Test
0,136 (−0,221; 0,141)
0,121 (−0,114; 0,151)
0,671 (−1,21; 0,83)
0,541 (−1,51; 1,19)
0,337 (−1,17; 0,98)
Sps
−0,015 (−0,0171; −0,0139)
−0,013 (−0,031; −0,009)
−0,065 (−1,11; −0,03)
−0,047 (−1,76; −0,04)
−0,018 (−0,29; −0,03)
Pul
−0,012 (−0,0729; −0,011)
−0,015 (−0,021; −0,008)
−0,023 (−0,045; −0,012)
−0,014 (−0,21; −0,04)
−0,091 (−1,21; −0,02)
OSAT
−0,013 (−0,018; 0,011)
−0,021 (−0,033; 0,016)
−0,156 (−0,211; 0,06)
−0,11 (−0,35; −0,04)
−0,17 (−0,29; −0,13)
Sed-level (1, ) [Sed1]
Sed2
5,43 (3,98; 6,83)
4,91 (3,71; 5,61)
Sed3
5,65 (2,68; 7,26)
4,73 (3,86; 5,12)
Sed4
5,21 (3,12; 5,93)
5,13 (4,67; 5,37)
Sed5
5,85 (3,29; 6,81)
4,88 (4,21; 5,17)
Sed6
5,43 (4,71; 4,81)
5,13 (4,91; 5,61)
Sed-level (2, ) [Sed1]
Sed2
5,13 (4,81; 5,61)
5,41 (4,71; 5,91)
Sed3
5,29 (4,61; 5,79)
5,16 (4,51; 5,56)
Sed4
5,41 (4,71; 4,81)
5,23 (4,91; 5,61)
Sed5
5,35 (4,91; 5,81)
5,44 (5,01; 5,96)
Sed6
5,25 (4,12; 5,93)
5,23 (4,67; 5,37)
Sed-level (3, ) [Sed1]
Sed2
5,29 (4,87; 5,65)
5,96 (5,26; 6,36)
Sed3
5,17 (4,67; 5,81)
5,91 (5,31; 6,31)
Sed4
5,27 (4,71; 5,67)
5,77 (5,27; 6,28)
Sed5
5,13 (4,55; 5,87)
5,85 (5,11; 6,51)
Sed6
5,31 (4,71; 5,81)
5,33 (4,91; 5,61)
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
